Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Beaudet

Showing results (221-230 of 456) with videos related to

Pageof 46
Sort By:
Plos Genetics|January 4, 2014
Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse modelLinyan Meng, Richard Erwin Person, Wei Huang, et al.
American Journal of Medical Genetics. Part A|June 24, 2004
Cognitive and adaptive behavior profiles of children with Angelman syndromeSarika U Peters, Jan Goddard-Finegold, Arthur L Beaudet, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
Multiple advantages of alpha-fetoprotein as a marker for in vivo gene transferW K O'Neal, E Rose, H Zhou, et al.
Human Gene Therapy|February 18, 2004
Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primatesNicola Brunetti-Pierri, Donna J Palmer, Arthur L Beaudet, et al.
Gene|February 26, 2004
Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient miceLucio Pastore, L Maria Belalcazar, Kazuhiro Oka, et al.
The Journal of Experimental Medicine|January 6, 2000
P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient miceR G Collins, R Velji, N V Guevara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2001
A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vectorH Zhou, T Zhao, L Pastore, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presenceE A Sweeney, G V Priestley, B Nakamoto, et al.
BMC Medical Genetics|November 29, 2011
High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsyLarissa R Stewart, April L Hall, Sung-Hae L Kang, et al.
Genesis (New York, N.Y. : 2000)|January 7, 2006
Mouse imprinting defect mutations that model Angelman syndromeMei-Yi Wu, Ken-Shiung Chen, Jan Bressler, et al.
Pageof 46

Showing results (221-230 of 456) with videos related to

Sort By:
Pageof 46
Plos Genetics|January 4, 2014
Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse modelLinyan Meng, Richard Erwin Person, Wei Huang, et al.
American Journal of Medical Genetics. Part A|June 24, 2004
Cognitive and adaptive behavior profiles of children with Angelman syndromeSarika U Peters, Jan Goddard-Finegold, Arthur L Beaudet, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
Multiple advantages of alpha-fetoprotein as a marker for in vivo gene transferW K O'Neal, E Rose, H Zhou, et al.
Human Gene Therapy|February 18, 2004
Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primatesNicola Brunetti-Pierri, Donna J Palmer, Arthur L Beaudet, et al.
Gene|February 26, 2004
Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient miceLucio Pastore, L Maria Belalcazar, Kazuhiro Oka, et al.
The Journal of Experimental Medicine|January 6, 2000
P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient miceR G Collins, R Velji, N V Guevara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2001
A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vectorH Zhou, T Zhao, L Pastore, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presenceE A Sweeney, G V Priestley, B Nakamoto, et al.
BMC Medical Genetics|November 29, 2011
High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsyLarissa R Stewart, April L Hall, Sung-Hae L Kang, et al.
Genesis (New York, N.Y. : 2000)|January 7, 2006
Mouse imprinting defect mutations that model Angelman syndromeMei-Yi Wu, Ken-Shiung Chen, Jan Bressler, et al.
Pageof 46